its chronic not acute..im sure a few posters here will highlight perfectly the difference!
Sanofi paid 1.9.bill usd for Kadmons Rezurock..first in class treatment for chronic GVHD.
Our IND for aGVHD, i.e second generation, one time only donor, excellent phase 1 results, no WTF is in this concotion this time around scenario!!..should get us some serious attention...
Thats just cyp 001...Acorns and Oak trees and all that!!
cyp 002 Cli
cyp..oo4 OA knee.
cyp ??..cypatch
But we need less non execs and more full timers..especially a spat wearing go getting salesmen!!
justa bit more research for me..but im getting there!!
1.9 billion for chronic gvhd acquisition
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
-0.005(2.08%) |
Mkt cap ! $42.21M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 22.0¢ | $26.42K | 118.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 121149 | 2 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
24.0¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 24.0¢ | 24.0¢ | 24.0¢ | 9174 | ||
| Last updated 10.44am 06/05/2024 ? | |||||
| CYP (ASX) Chart |